Betnovate Skin Cream 20 g

Babies: Use with caution. Lactating mother: Betnovate cream is safe to use in breastfeeding.
However, limited human data suggest that the drug does not excrete in breast milk. Consult your physician before using.
Pregnancy: Betnovate cream may be unsafe during pregnancy. Limited human studies, animal studies have shown harmful effects on the developing baby.
Consult your physician before use. Driving: Betnovate cream usually does not affect your ability to drive or operate machinery.
Alcohol: Betnovate cream may interact with alcohol. Consult a doctor before consuming alcohol with betnovate.
Kidney: Take betnovate cream with caution, especially if you have a history of kidney diseases/conditions. The dose may be adjusted by your doctor as required.
Liver: Take betnovate cream with caution, especially if you have a history of liver diseases/conditions. The dose may be adjusted by your doctor as required..

Itching Burning Dryness Redness Irritation, stinging Acne Unwanted hair growth Skin colour changes Bruising or shiny skin Tiny red bumps or rash around the mouth Small white or red bumps on the skin.

Betnovate cream is a corticosteroid, which works by depressing the formation, release and activity of chemical mediators of inflammation.

If you miss an application, apply it as soon as you remember. However, if it is almost time for your next application, ignore the missed dose and go back to using it as you would normally..

• Betnovate cream is used to treat the redness, swelling, itching, and discomfort of various skin conditions • It should be applied to the affected areas as a thin film two or three times daily generally or as advised by your doctor • Don't use it more often or for longer than advised by your doctor • Don't cover the area being treated with airtight dressings such as bandages unless directed by a doctor, as this may increase the risk of side effects • If you think the area of skin you are treating has become infected you should stop using betnovate cream and consult your doctor • Consult your doctor if your skin condition has not improved after two weeks of treatment • Do not expose to sunlight, as it may cause sun tanning.

• Betnovate + Aceclofenac: Concurrent use leads to increase the risk of gastric irritation • Betnovate + Alectinib: Concurrent use leads to increase the mechanism of alectinib • Betnovate + Aminophylline: Concurrent use leads to increase the metabolism of aminophylline • Betnovate + Amiodarone: Concurrent use leads to decrease the metabolism betnovate • Betnovate + Calcitriol: Concurrent use leads to decrease the therapeutic efficacy of calcitriol • Betnovate + Vinblastin: Concurrent use leads to increase the metabolism of vinblastine • Betnovate + Triazolam: Concurrent use leads to increase the risk or severity of myopathy, rhabdomyolysis, and myoglobinuria • Betnovate + Thalidomide: Concurrent use leads to increase the risk or severity of adverse effects • Betnovate + Sulfasalazine: Concurrent use leads to increase the risk or severity of gastrointestinal irritation when combined with sulfasalazine • Betnovate + Sulfisoxozole: Concurrent use leads to increase the risk or severity of hyperglycaemia.